Company facts
- Founded
- 2018
- Employees
- 372
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: MIRM
- Subsidiaries
- Bluejay Therapeutics, Satiogen
About
Mirum Pharmaceuticals is a leading rare disease company with a global footprint of approved products and a broad pipeline of investigational medicines. Purpose-built to bring forward breakthrough medicines for people with overlooked conditions, Mirum combines deep rare disease expertise with strong connections to patie…